These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Stopping clinical trials because of treatment ineffectiveness: a comparison of a futility design with a method of stochastic curtailment. Whitehead J; Matsushita T Stat Med; 2003 Mar; 22(5):677-87. PubMed ID: 12587099 [TBL] [Abstract][Full Text] [Related]
27. Predicting clinical trial results based on announcements of interim analyses. Broglio KR; Stivers DN; Berry DA Trials; 2014 Mar; 15():73. PubMed ID: 24607270 [TBL] [Abstract][Full Text] [Related]
28. A two-stage group-sequential design for delayed treatment responses with the possibility of trial restart. Schüürhuis S; Konietschke F; Kunz CU Stat Med; 2024 May; 43(12):2368-2388. PubMed ID: 38564226 [TBL] [Abstract][Full Text] [Related]
29. Stopping clinical trials early for benefit: impact on estimation. Freidlin B; Korn EL Clin Trials; 2009 Apr; 6(2):119-25. PubMed ID: 19342463 [TBL] [Abstract][Full Text] [Related]
30. Impact of safety monitoring on error probabilities of binary efficacy outcome analyses in large phase III group sequential trials. Weng Y; Zhao W; Palesch Y Pharm Stat; 2012; 11(4):310-7. PubMed ID: 22589042 [TBL] [Abstract][Full Text] [Related]
31. Group sequential designs using a family of type I error probability spending functions. Hwang IK; Shih WJ; De Cani JS Stat Med; 1990 Dec; 9(12):1439-45. PubMed ID: 2281231 [TBL] [Abstract][Full Text] [Related]
32. Early stopping rules and long-term follow-up in phase III trials. Pignon JP; Arriagada R Lung Cancer; 1994 Mar; 10 Suppl 1():S151-9. PubMed ID: 8087505 [TBL] [Abstract][Full Text] [Related]
33. Optimal conditional error functions for the control of conditional power. Brannath W; Bauer P Biometrics; 2004 Sep; 60(3):715-23. PubMed ID: 15339294 [TBL] [Abstract][Full Text] [Related]
35. Interim analyses and stopping rules in cancer clinical trials. Whitehead J Br J Cancer; 1993 Dec; 68(6):1179-85. PubMed ID: 8260370 [TBL] [Abstract][Full Text] [Related]
36. Group sequential t-test for clinical trials with small sample sizes across stages. Shao J; Feng H Contemp Clin Trials; 2007 Sep; 28(5):563-71. PubMed ID: 17434814 [TBL] [Abstract][Full Text] [Related]
37. Multiplicity in randomised trials II: subgroup and interim analyses. Schulz KF; Grimes DA Lancet; 2005 May 7-13; 365(9471):1657-61. PubMed ID: 15885299 [TBL] [Abstract][Full Text] [Related]
38. Clinical trial designs based on sequential conditional probability ratio tests and reverse stochastic curtailing. Tan M; Xiong X; Kutner MH Biometrics; 1998 Jun; 54(2):682-95. PubMed ID: 9629648 [TBL] [Abstract][Full Text] [Related]
39. Practical problems in interim analyses, with particular regard to estimation. Pocock SJ; Hughes MD Control Clin Trials; 1989 Dec; 10(4 Suppl):209S-221S. PubMed ID: 2605969 [TBL] [Abstract][Full Text] [Related]
40. Interim analyses of data as they accumulate in laboratory experimentation. Ludbrook J BMC Med Res Methodol; 2003 Aug; 3():15. PubMed ID: 12930561 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]